{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:13:43Z","timestamp":1758816823092},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,6,12]],"date-time":"2013-06-12T00:00:00Z","timestamp":1370995200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s11255-013-0480-5","type":"journal-article","created":{"date-parts":[[2013,6,11]],"date-time":"2013-06-11T10:12:13Z","timestamp":1370945533000},"page":"49-56","source":"Crossref","is-referenced-by-count":11,"title":["Comparison of prednisolone and lamivudine combined therapy with prednisolone monotherapy on carriers of hepatitis B virus with IgA nephropathy: a prospective cohort study"],"prefix":"10.1007","volume":"46","author":[{"given":"Jing","family":"Fang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenge","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,12]]},"reference":[{"key":"480_CR1","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1056\/NEJMra020109","volume":"347","author":"JV Donadio","year":"2002","unstructured":"Donadio JV, Grande JP (2002) IgA nephropathy. N Engl J Med 347:738\u2013748","journal-title":"N Engl J Med"},{"key":"480_CR2","first-page":"834","volume":"12","author":"G Liu","year":"2004","unstructured":"Liu G, Ma XZ, Zou WZ et al (2004) Comparative analysis of kidney diseases configuration in renal biopsy during recent 10\u00a0years. Clin Intern Med 12:834\u2013838","journal-title":"Clin Intern Med"},{"key":"480_CR3","unstructured":"http:\/\/www.who.int\/csr\/disease\/hepatitis\/whocdscsrlyo20022\/en\/index4.html"},{"key":"480_CR4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000330189","volume":"34","author":"T Moriyama","year":"2011","unstructured":"Moriyama T, Amemiya N, Ochi A et al (2011) Comparison of steroids and angiotensin receptor blockers for patients with advanced IgA nephropathy and impaired renal function. Am J Nephrol 34:233\u2013240","journal-title":"Am J Nephrol"},{"key":"480_CR5","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1681\/ASN.2011030221","volume":"22","author":"J Floege","year":"2011","unstructured":"Floege J, Eitner F (2011) Current therapy for IgA nephropathy. J Am Soc Nephrol 22:1785\u20131794","journal-title":"J Am Soc Nephrol"},{"key":"480_CR6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1665-2681(19)31565-0","volume":"10","author":"Y Zhou","year":"2011","unstructured":"Zhou Y, Yuan WJ, Zhu N (2011) The efficacy of anti-viral therapy on hepatitis B virus-associated glomerulonephritis: a systematic review and meta-analysis. Ann Hepatol 10:165\u2013173","journal-title":"Ann Hepatol"},{"key":"480_CR7","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1523-1755.1999.00273.x","volume":"55","author":"J Zimmermann","year":"1999","unstructured":"Zimmermann J, Herrlinger S, Pruy A (1999) Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55:648\u2013658","journal-title":"Kidney Int"},{"key":"480_CR8","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1046\/j.1523-1755.1999.00422.x","volume":"55","author":"P Stenvinkel","year":"1999","unstructured":"Stenvinkel P, Heimburger O, Paultre F et al (1999) Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 55:1899\u20131911","journal-title":"Kidney Int"},{"key":"480_CR9","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/ki.2009.243","volume":"76","author":"A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society","year":"2009","unstructured":"A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society (2009) The oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 76:534\u2013545","journal-title":"Kidney Int"},{"key":"480_CR10","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/ki.2009.168","volume":"76","author":"A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society","year":"2009","unstructured":"A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society (2009) The oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int 76:546\u2013556","journal-title":"Kidney Int"},{"key":"480_CR11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.semnephrol.2004.01.001","volume":"24","author":"G D\u2019Amico","year":"2004","unstructured":"D\u2019Amico G (2004) Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol 24:179\u2013196","journal-title":"Semin Nephrol"},{"key":"480_CR12","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1053\/ajkd.2001.27689","volume":"38","author":"LP Bartosik","year":"2001","unstructured":"Bartosik LP, Lajoie G, Sugar L et al (2001) Predicting progression in IgA nephropathy. Am J Kidney Dis 38:728\u2013735","journal-title":"Am J Kidney Dis"},{"key":"480_CR13","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/ndt\/gfr482","volume":"27","author":"D Maixnerova","year":"2012","unstructured":"Maixnerova D, Bauerova L, Skibova J et al (2012) The retrospective analysis of 343 Czech patients with IgA nephropathy-one centre experience. Nephrol Dial Transplant 27:1492\u20131498","journal-title":"Nephrol Dial Transplant"},{"key":"480_CR14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s11255-012-0251-8","volume":"45","author":"A Ochi","year":"2013","unstructured":"Ochi A, Moriyama T, Takei T, Uchida K, Nitta K (2013) Comparison between steroid pulse therapy alone and in combination with tonsillectomy for IgA nephropathy. Int Urol Nephrol 45:469\u2013476","journal-title":"Int Urol Nephrol"},{"key":"480_CR15","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s11255-011-0109-5","volume":"44","author":"T Moriyama","year":"2012","unstructured":"Moriyama T, Nakayama K, Iwasaki C et al (2012) Severity of nephrotic IgA nephropathy according to the Oxford classification. Int Urol Nephrol 44:1177\u20131184","journal-title":"Int Urol Nephrol"},{"key":"480_CR16","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3748\/wjg.v16.i6.770","volume":"16","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Zhou JH, Yin XL, Wang FY (2010) Treatment of hepatitis B virus-associated glomerulonephritis: a meta-analysis. World J Gastroenterol 16:770\u2013777","journal-title":"World J Gastroenterol"},{"key":"480_CR17","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1016\/S0168-8278(03)00155-7","volume":"39","author":"YF Liaw","year":"2003","unstructured":"Liaw YF (2003) Results of lamivudine trials in Asia. J Hepatol 39:S111\u2013S115","journal-title":"J Hepatol"},{"key":"480_CR18","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1038\/sj.ki.5001908","volume":"70","author":"SK Olsen","year":"2006","unstructured":"Olsen SK, Brown RS Jr (2006) Hepatitis B treatment: lessons for the nephrologist. Kidney Int 70:1897\u20131904","journal-title":"Kidney Int"},{"key":"480_CR19","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/j.1440-1746.2004.03428.x","volume":"19","author":"TT Chang","year":"2004","unstructured":"Chang TT, Lai CL, Chien RN et al (2004) Four years of lamivudine treatment in Chinese patients with chronic hepatitis B. J Gastroenterol Hepatol 19:1276\u20131282","journal-title":"J Gastroenterol Hepatol"},{"key":"480_CR20","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S1665-2681(19)31554-6","volume":"10","author":"S Unverdi","year":"2011","unstructured":"Unverdi S, Ceri M, K\u00f6kl\u00fc S (2011) Tenofovir as a first line option for prophylaxis in a patient with hepatitis B virus associated nephrotic syndrome. Ann Hepatol 10:372\u2013373","journal-title":"Ann Hepatol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-013-0480-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-013-0480-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-013-0480-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T01:05:24Z","timestamp":1563152724000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-013-0480-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,12]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["480"],"URL":"https:\/\/doi.org\/10.1007\/s11255-013-0480-5","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,12]]}}}